Cell-Matrix Microspheres via Controlled Phase Transition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing cell-matrix microspheres face challenges such as low encapsulation efficiency, poor mechanical stability, and harsh fabrication conditions, which hinder their use in cell therapy and biomolecule production, particularly with materials like collagen and hyaluronic acid that are essential for cell growth but difficult to stabilize.
Innovation Solution
A method is developed to produce stable cell-matrix microspheres with up to 100% encapsulation efficiency using a formulation including cells, a first extracellular matrix like collagen, and other biomolecules, with a modified droplet generation process that allows for controlled phase transition and mechanical stability, enabling their use in cell therapeutics and biomolecule production without harsh conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If natural extracellular matrix materials like collagen and hyaluronic acid are used to support cell growth, then cell attachment and growth are improved, but mechanical stability and shape stability deteriorate
Solution Approach 1:
The patent uses composite materials by combining natural extracellular matrix materials (collagen, hyaluronic acid) with synthetic polymers or crosslinking agents to create microspheres that maintain both cell-supportive properties and mechanical stability. The composite structure allows the natural matrix to provide biochemical cues for cell growth while the synthetic components provide structural integrity.
Solution Approach 2:
The patent applies parameter changes by modifying the physical and chemical properties of the extracellular matrix materials through controlled crosslinking, concentration adjustments, and phase transition conditions. These parameter modifications enable the materials to achieve adequate mechanical stability while preserving their cell-supportive functions.
2Ease of manufacture
If emulsification and stirring methods are used to produce cell-matrix microspheres, then microsphere formation is achieved, but shear stress damages the microspheres and encapsulation efficiency decreases
Solution Approach 1:
The patent replaces the traditional mechanical emulsification and stirring methods with a droplet generation system that uses controlled dispensing and phase transition. This substitution eliminates the harmful shear stress while maintaining microsphere formation capability, thereby improving encapsulation efficiency.
Solution Approach 2:
The patent utilizes phase transitions of the matrix material (e.g., temperature-induced gelation of collagen or hyaluronic acid) to form stable microspheres after gentle droplet generation. The phase transition occurs after droplet formation, avoiding mechanical stress during the critical encapsulation phase while still achieving solid microsphere structure.
3Reliability
If microencapsulation is used to protect cells, then cell viability is improved, but cell migration and penetration are prevented
Solution Approach 1:
The patent employs flexible and biodegradable microsphere matrices made from natural extracellular materials that allow cell migration and penetration. The matrix structure is designed to be permeable and dynamically responsive, enabling cells to move through and integrate with the microsphere construct while remaining protected during initial encapsulation.
Solution Approach 2:
The patent creates dynamic microsphere systems where the matrix properties can change over time. The microspheres transition from a protective confinement structure to a more open, integrative structure that facilitates cell migration and host tissue integration, combining both protection and adaptability functions.
4Productivity
If microcarrier technology is used for large scale cell culture, then productivity is improved, but fabrication conditions become harsh and cost increases
Solution Approach 1:
The patent employs self-assembling extracellular matrix materials that spontaneously form stable microspheres under physiological conditions without requiring harsh fabrication processes. The materials self-organize into microcarrier structures through controlled phase transitions, eliminating the need for complex fabrication equipment and reducing production costs while maintaining scalability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high cell viability and efficient production of cell-matrix microspheres with controlled proliferation and protein productivity, enhancing their application in cell therapy and tissue engineering while reducing costs and complexity.
Implementation Method 1
with a modified droplet generation process that allows for controlled phase transition and mechanical stability
Data Source
Figure 1~2
Figure 3
Figure 4A~4C
AI summary
A method has been developed to produce stable cell-matrix microspheres with up to 100% encapsulation efficiency and high cell viability, using matrix or biomaterial systems with poor shape and mechanical stability for applications including cell therapeutics via microinjection or surgical implantation, 3D culture for in vitro expansion without repeated cell splitting using enzymatic digestion or mechanical dissociation and for enhanced production of therapeutic biomolecules, and in vitro modelling for morphogenesis studies. The modified droplet generation method is simple and scalable and enables the production of cell-matrix microspheres when the matrix or biomaterial system used has low concentration, with slow phase transition, with poor shape and mechanical stability.